Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ballantyne

Showing results (521-530 of 999) with videos related to

Pageof 100
Sort By:
European Heart Journal|October 15, 2010
Relationship between circulating levels of RANTES (regulated on activation, normal T-cell expressed, and secreted) and carotid plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) Carotid MRI StudySalim S Virani, Vijay Nambi, Ron Hoogeveen, et al.
European Journal of Preventive Cardiology|January 16, 2026
Effects of Icosapent Ethyl on Risk and Duration of Hospitalizations and Death in REDUCE-ITMichael Szarek, Deepak L Bhatt, Michael Miller, et al.
American Journal of Epidemiology|February 8, 2007
A prospective study of plasma ferritin level and incident diabetes: the Atherosclerosis Risk in Communities (ARIC) StudyMegan L Jehn, Eliseo Guallar, Jeanne M Clark, et al.
American Heart Journal|October 11, 2011
Frequency and correlates of treatment intensification for elevated cholesterol levels in patients with cardiovascular diseaseSalim S Virani, LeChauncy D Woodard, Supicha S Chitwood, et al.
Circulation. Arrhythmia and Electrophysiology|January 10, 2012
Blood lipid levels, lipid-lowering medications, and the incidence of atrial fibrillation: the atherosclerosis risk in communities studyFaye L Lopez, Sunil K Agarwal, Richard F Maclehose, et al.
The American Journal of Physiology|December 1, 1995
Myocardial ischemia and reperfusion: a murine modelL H Michael, M L Entman, C J Hartley, et al.
American Heart Journal|November 9, 2016
Comparative effectiveness of outpatient cardiovascular disease and diabetes care delivery between advanced practice providers and physician providers in primary care: Implications for care under the Affordable Care ActSalim S Virani, Julia M Akeroyd, David J Ramsey, et al.
Journal of the American College of Cardiology|September 10, 2021
Technology-Assisted Self-Selection of Candidates for Nonprescription Statin TherapySteven E Nissen, Howard G Hutchinson, Tracy Y Wang, et al.
Journal of the American College of Cardiology|August 15, 2020
Lipoprotein(a) and Family History Predict Cardiovascular Disease RiskAnurag Mehta, Salim S Virani, Colby R Ayers, et al.
Journal of Clinical Lipidology|July 30, 2013
Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndromeJennifer G Robinson, Christie M Ballantyne, Willa A Hsueh, et al.
Pageof 100

Showing results (521-530 of 999) with videos related to

Sort By:
Pageof 100
European Heart Journal|October 15, 2010
Relationship between circulating levels of RANTES (regulated on activation, normal T-cell expressed, and secreted) and carotid plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) Carotid MRI StudySalim S Virani, Vijay Nambi, Ron Hoogeveen, et al.
European Journal of Preventive Cardiology|January 16, 2026
Effects of Icosapent Ethyl on Risk and Duration of Hospitalizations and Death in REDUCE-ITMichael Szarek, Deepak L Bhatt, Michael Miller, et al.
American Journal of Epidemiology|February 8, 2007
A prospective study of plasma ferritin level and incident diabetes: the Atherosclerosis Risk in Communities (ARIC) StudyMegan L Jehn, Eliseo Guallar, Jeanne M Clark, et al.
American Heart Journal|October 11, 2011
Frequency and correlates of treatment intensification for elevated cholesterol levels in patients with cardiovascular diseaseSalim S Virani, LeChauncy D Woodard, Supicha S Chitwood, et al.
Circulation. Arrhythmia and Electrophysiology|January 10, 2012
Blood lipid levels, lipid-lowering medications, and the incidence of atrial fibrillation: the atherosclerosis risk in communities studyFaye L Lopez, Sunil K Agarwal, Richard F Maclehose, et al.
The American Journal of Physiology|December 1, 1995
Myocardial ischemia and reperfusion: a murine modelL H Michael, M L Entman, C J Hartley, et al.
American Heart Journal|November 9, 2016
Comparative effectiveness of outpatient cardiovascular disease and diabetes care delivery between advanced practice providers and physician providers in primary care: Implications for care under the Affordable Care ActSalim S Virani, Julia M Akeroyd, David J Ramsey, et al.
Journal of the American College of Cardiology|September 10, 2021
Technology-Assisted Self-Selection of Candidates for Nonprescription Statin TherapySteven E Nissen, Howard G Hutchinson, Tracy Y Wang, et al.
Journal of the American College of Cardiology|August 15, 2020
Lipoprotein(a) and Family History Predict Cardiovascular Disease RiskAnurag Mehta, Salim S Virani, Colby R Ayers, et al.
Journal of Clinical Lipidology|July 30, 2013
Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndromeJennifer G Robinson, Christie M Ballantyne, Willa A Hsueh, et al.
Pageof 100